In combination with ionizing radiotherapy that enhances T cell antitumor immunity (Demaria and Formenti, 2012), CD47 blockade in effector T cells is therefore sufficient to inhibit tumor growth, thus offsetting the widely spread opinion that CD47 blockade anticancer effects are attributed to phagocytosis of cancer cells by macrophages. This evidence concerns the gene CD47 and neoplasm.